Manning Paul B's Form 4/A amendment
AmendedCandel Therapeutics, Inc. (CADL) · filed Aug 4, 2021
- Accession no.
- 0000899243-21-031614
- Filed
- Aug 4, 2021
- Trade date
- Jul 29, 2021
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 2, 2021
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $13.0M. It was filed 6 days after the trade.
This amendment replaces 0000899243-21-031096 (filed Aug 2, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning Paul BCIK 0001494695 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Common Stock | CConversionAcquired | +679,158 | – | – | 679,158 | Indirect | |
| Jul 29, 2021 | Common Stock | CConversionAcquired | +553,752 | – | – | 553,752 | Indirect | |
| Jul 29, 2021 | Common Stock | PPurchaseAcquired | +1,625,000 | $8.00 | +$13,000,000 | 1,681,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2021 | Common Stock | CConversionDisposed | −679,158 | $0.00 | $0 | 0 | Indirect | |
| Jul 29, 2021 | Common Stock | CConversionDisposed | −553,752 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.